Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation

Annals of Hematology

Volumn 91, Issue 7, 2012, Pages 1115-1120

  Ziegler, Patrick ^a   Schrezenmeier, Hubert ^b,c   Akkad, Jamil ^d   Brassat, Ute ^e   Vankann, Lucia ^a   Panse, Jens ^a   Wilop, Stefan ^a   Balabanov, Stefan ^e   Schwarz, Klaus ^b,c   Martens, Uwe M ^d   Brümmendorf, Tim H ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b German Red Cross Blood Donation Service Baden Wuerttemberg Hessen   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d SLK Kliniken Heilbronn   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Androgen treatment; Aplastic anemia; Bone marrow failure; Telomerase; Telomere

Indexed keywords

ALANINE; CD34 ANTIGEN; CYCLOSPORIN A; DYSKERIN; HLA DR ANTIGEN; STEM CELL FACTOR RECEPTOR; TELOMERASE REVERSE TRANSCRIPTASE; TESTOSTERONE UNDECANOATE; THREONINE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; AMINO ACID SUBSTITUTION; ANDROGEN THERAPY; APLASTIC ANEMIA; ARTICLE; BONE MARROW APLASIA; BONE MARROW DISEASE; CASE REPORT; CAUSE OF DEATH; CODON; CYTOGENETICS; DRUG RESPONSE; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; GENE MUTATION; GENE SEQUENCE; GRANULOCYTE; HAPLOINSUFFICIENCY; HEMATOPOIETIC STEM CELL; HETEROZYGOSITY; HUMAN; INFECTION; MALE; MEGAKARYOPOIESIS; MONOSOMY 7; PANCYTOPENIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TELOMERE; TELOMERE SHORTENING; THROMBOCYTE COUNT;

ANDROGENS; ANEMIA, APLASTIC; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; TELOMERASE; TELOMERE; TREATMENT OUTCOME;

EID: 84862766157     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1454-x     Document Type: Article

References (23)

1. NS Young J Maciejewski 1997 The pathophysiology of acquired aplastic anemia N Engl J Med 336 19 1365 1372 9134878 10.1056/NEJM199705083361906 1:CAS:528:DyaK2sXjtlOru7w%3D
2. F Beier S Balabanov T Buckley K Dietz U Hartmann M Rojewski L Kanz H Schrezenmeier TH Brummendorf 2005 Accelerated telomere shortening in glycosylphosphatidylinositol (GPI)-negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by proaerolysin flow-FISH Blood 106 2 531 533 15811960 10.1182/blood-2004-10-3996 1:CAS:528:DC%2BD2MXmtleqsbk%3D
3. GM Baerlocher EM Sloand NS Young PM Lansdorp 2007 Telomere length in paroxysmal nocturnal hemoglobinuria correlates with clone size Exp Hematol 35 12 1777 1781 17697745 10.1016/j.exphem.2007.06.010 1:CAS:528:DC%2BD2sXhtlGjtLnM
4. SE Ball FM Gibson S Rizzo JA Tooze JC Marsh EC Gordon-Smith 1998 Progressive telomere shortening in aplastic anemia Blood 91 10 3582 3592 9572992 1:CAS:528:DyaK1cXjtFersrs%3D
5. TH Brummendorf JP Maciejewski J Mak NS Young PM Lansdorp 2001 Telomere length in leukocyte subpopulations of patients with aplastic anemia Blood 97 4 895 900 11159514 10.1182/blood.V97.4.895 1:CAS:528:DC%2BD3MXht1Gjur4%3D
6. P Scheinberg JN Cooper EM Sloand CO Wu RT Calado NS Young 2010 Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia JAMA 304 12 1358 1364 20858879 10.1001/jama.2010.1376 1:CAS:528:DC%2BC3cXht1SjtLnF
7. MW Drummond S Balabanov TL Holyoake TH Brummendorf 2007 Concise review: telomere biology in normal and leukemic hematopoietic stem cells Stem Cells 25 8 1853 1861 17510216 10.1634/stemcells.2007-0057 1:CAS:528:DC%2BD2sXhtVSqsbnK
8. RT Calado NS Young 2009 Telomere diseases N Engl J Med 361 24 2353 2365 20007561 10.1056/NEJMra0903373 1:CAS:528:DC%2BD1MXhsFGqsrbO
9. GM Baerlocher I Vulto G de Jong PM Lansdorp 2006 Flow cytometry and FISH to measure the average length of telomeres (flow FISH) Nat Protoc 1 5 2365 2376 17406480 10.1038/nprot.2006.263 1:CAS:528:DC%2BD2sXhtFGjtLbL
10. U Hartmann TH Brummendorf S Balabanov C Thiede T Illme M Schaich 2005 Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities Haematologica 90 3 307 316 15749662 1:CAS:528:DC%2BD2MXjtFegu78%3D
11. RM Cawthon 2009 Telomere length measurement by a novel monochrome multiplex quantitative PCR method Nucleic Acids Res 37 3 e21 19129229 10.1093/nar/gkn1027
12. N Rufer TH Brummendorf S Kolvraa C Bischoff K Christensen L Wadsworth M Schulzer PM Lansdorp 1999 Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood J Exp Med 190 2 157 167 10432279 10.1084/jem.190.2.157 1:CAS:528:DyaK1MXkslSjtbs%3D
13. H Yamaguchi RT Calado H Ly S Kajigaya GM Baerlocher SJ Chanock PM Lansdorp NS Young 2005 Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia N Engl J Med 352 14 1413 1424 15814878 10.1056/NEJMoa042980 1:CAS:528:DC%2BD2MXjtVWltr8%3D
14. P Martinez MA Blasco 2011 Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins Nat Rev Cancer 11 3 161 176 21346783 10.1038/nrc3025 1:CAS:528:DC%2BC3MXisVagtLY%3D
15. SW Knight NS Heiss TJ Vulliamy S Greschner G Stavrides GS Pai G Lestringant N Varma PJ Mason I Dokal A Poustka 1999 X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene Am J Hum Genet 65 1 50 58 10364516 10.1086/302446 1:CAS:528:DyaK1MXltlOgu7o%3D
16. TJ Vulliamy SW Knight PJ Mason I Dokal 2001 Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita Blood Cells Mol Dis 27 2 353 357 11259155 10.1006/bcmd.2001.0389 1:CAS:528:DC%2BD3MXhvFKjtr0%3D
17. ZT Xin AD Beauchamp RT Calado JW Bradford JA Regal A Shenoy Y Liang PM Lansdorp NS Young H Ly 2007 Functional characterization of natural telomerase mutations found in patients with hematologic disorders Blood 109 2 524 532 16990594 10.1182/blood-2006-07-035089 1:CAS:528:DC%2BD2sXivVyku70%3D
18. S Kyo M Takakura T Kanaya W Zhuo K Fujimoto Y Nishio A Orimo M Inoue 1999 Estrogen activates telomerase Cancer Res 59 23 5917 5921 10606235 1:CAS:528:DC%2BD3cXht1SnsQ%3D%3D
19. RT Calado WT Yewdell KL Wilkerson JA Regal S Kajigaya CA Stratakis NS Young 2009 Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells Blood 114 11 2236 2243 19561322 10.1182/blood-2008-09-178871 1:CAS:528:DC%2BD1MXhtFOgtrfN
20. K Bartolovic S Balabanov B Berner HJ Buhring M Komor S Becker D Hoelzer L Kanz WK Hofmann TH Brummendorf 2005 Clonal heterogeneity in growth kinetics of CD34 + CD38- human cord blood cells in vitro is correlated with gene expression pattern and telomere length Stem Cells 23 7 946 957 15941854 10.1634/stemcells.2004-0311 1:CAS:528:DC%2BD2MXhtVemsrbJ
21. JC Marsh SE Ball J Cavenagh P Darbyshire I Dokal EC Gordon-Smith J Keidan A Laurie A Martin J Mercieca SB Killick R Stewart JA Yin 2009 Guidelines for the diagnosis and management of aplastic anaemia Br J Haematol 147 1 43 70 19673883 10.1111/j.1365-2141.2009.07842.x 1:CAS:528:DC%2BD1MXhtlWltbbI
22. T Chuhjo H Yamazaki M Omine S Nakao 2008 Danazol therapy for aplastic anemia refractory to immunosuppressive therapy Am J Hematol 83 5 387 389 18161784 10.1002/ajh.21118 1:CAS:528:DC%2BD1cXmvVSgtrk%3D
23. JC Jaime-Perez PR Colunga-Pedraza CD Gomez-Ramirez CH Gutierrez-Aguirre OG Cantu-Rodriguez LC Tarin-Arzaga D Gomez-Almaguer 2011 Danazol as first-line therapy for aplastic anemia Ann Hematol 90 5 523 527 21279356 10.1007/s00277-011-1163-x 1:CAS:528:DC%2BC3MXktFOqu70%3D